Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9202 USD | +1.12% | +1.11% | +4.68% |
Mar. 15 | Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2022 | 6.94M | Sales 2023 | 8.01M | Capitalization | 5.25M |
---|---|---|---|---|---|
Net income 2022 | -21M | Net income 2023 | -5M | EV / Sales 2022 | -0.59 x |
Net cash position 2022 | 8.63M | Net cash position 2023 | 10.87M | EV / Sales 2023 | -0.7 x |
P/E ratio 2022 |
-0.2
x | P/E ratio 2023 |
-0.83
x | Employees | 4 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.4% |
1 day | +1.12% | ||
1 week | +1.11% | ||
Current month | +1.10% | ||
1 month | +0.16% | ||
3 months | -6.66% | ||
6 months | +3.60% | ||
Current year | +4.68% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Marchio
CEO | Chief Executive Officer | 72 | 20-11-30 |
Nancy Seretta
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Aaron Fox-Collis
AUD | Comptroller/Controller/Auditor | - | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Albert Marchio
CEO | Chief Executive Officer | 72 | 20-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.9202 | +1.12% | 1,253 |
24-05-02 | 0.91 | -2.67% | 2,370 |
24-05-01 | 0.935 | +2.72% | 200,606 |
24-04-30 | 0.9102 | 0.00% | 493 |
24-04-29 | 0.9102 | +0.01% | 2,912 |
Delayed Quote OTC Markets, May 03, 2024 at 03:38 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+4.68% | 5.5M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- FRTX Stock